---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-033842"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:04:25.354197+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Incannex partners with AASM Foundation, sponsors junior investigator sleep apnea grant

## Summary
- Partnership with AASM Foundation Corporate Recognition Program to support sleep apnea research.
- Sponsors a Focused Projects Grant for Junior Investigators in Diagnosis, Management, and Treatment of Sleep Apnea, to be awarded in 2026.
- IHL-42X Phase 2 DReAMzz study patient dosing expected within coming months; Phase 3 pathway defined.
- Previous milestones: positive Phase 2 results, FDA Fast Track designation, and establishment of Clinical Advisory Board.

## SEC filing metadata
- accession: 0001213900-26-033842
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/0001213900-26-033842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026033842/ea028334201-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-033842
- JSON: https://secwatch.observer/filing/0001213900-26-033842.json
- Plain text: https://secwatch.observer/filing/0001213900-26-033842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.